Opinion: Pfizer's Dividend Riskier Than It Looks, Even with a 7% Yield
Pfizer’s high dividend yield is eye-catching, but a big payout can hide hidden risks. This article explains the warni...
Tackling unexpected financial costs starts with a clear plan and small, steady changes you can implement today.
24,369 articlesPfizer’s high dividend yield is eye-catching, but a big payout can hide hidden risks. This article explains the warni...
Oil markets swung dramatically in the first half, with prices surging and then cooling. This guide explains what that...
A big earnings event could flip the script for Microsoft stock. This article breaks down why the bold idea of a parab...
A major institutional purchase has put Enviri in the spotlight. This article breaks down what the $43 million buy mea...
A lithium-extraction startup says its new method triples recovery while shortening timelines, accelerating toward com...
Nvidia's CEO argues the AI data-center expansion is only beginning, with trillions more in infrastructure needed. Mar...
Retail traders drove a large share of leveraged ETF activity in late 2025 as markets swung. This piece examines the p...
Morgan Stanley halves Lucid's price target to $5, keeping an Underweight rating as production stoppages and a leaders...
A high-profile Nvidia deal has propelled a semiconductor stock into the spotlight. This article breaks down whether t...
A sharp 27% drop for AppLovin stock has investors weighing risk and reward. This guide breaks down the business, the ...
If SpaceX ever files for an IPO, the prospectus would reveal the core drivers, the risks, and the questions investors...
As AI investment accelerates, layoffs already have surpassed last year’s total, with tech cuts leading the pace in Ju...